We are live on
!
Find out more
EAM
Empery Asset Management Portfolio holdings
AUM
$86.5M
This Fund
S&P 500
This Quarter
Est. Return
+2.25%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$83M
AUM Growth
-$30.4M
(-27%)
Cap. Flow
-$31M
Cap. Flow
% of AUM
-37.32%
Top 10 Holdings %
Top 10 Hldgs %
92.2%
Holding
43
New
12
Increased
1
Reduced
7
Closed
11
Avg Time Held
4.8
quarters
Top 10 Avg Time Held
0.5
quarters
Top 20 Avg Time Held
0.5
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Venu Holding Corp
VENU
|
+$5.81M |
| 2 |
Satellos Bioscience
MSLE
|
+$2.26M |
| 3 |
Big Sky Industrial
BSIN
|
+$1.98M |
| 4 |
Cyngn
CYN
|
+$1.86M |
| 5 |
SCYNEXIS
SCYX
|
+$1.43M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Immuneering
IMRX
|
+$17.6M |
| 2 |
Imperial Petroleum
IMPP
|
+$9.21M |
| 3 |
Aduro Clean Technologies
ADUR
|
+$5.92M |
| 4 |
Critical Metals Corp
CRML
|
+$4.14M |
| 5 |
Eos Energy Enterprises
EOSE
|
+$2.86M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 66.69% |
| 2 | Consumer Discretionary | 14.93% |
| 3 | Energy | 6.57% |
| 4 | Communication Services | 4.61% |
| 5 | Materials | 3.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
X4 Pharmaceuticals
XFOR
$290M
| $36.9M | 44.5% |
8,944,118
-6,987
| -0.1% | -$26.2K |
2025 Q4
1 quarter
|
|
2
Empery Digital
EMPD
$91.8M
| $12.4M | 14.93% |
2,930,345
| – | – |
2025 Q4
1 quarter
|
|
3
Precision BioSciences
DTIL
$186M
| $10.8M | 13.04% |
1,968,879
-225,756
| -10% | -$1.04M |
2025 Q4
1 quarter
|
|
|
4
Imperial Petroleum
IMPP
$254M
| $3.76M | 4.52% |
877,645
-2,305,306
| -72% | -$9.21M |
2025 Q4
1 quarter
|
|
|
5
Venu Holding Corp
VENU
$74.6M
| $3.34M | 4.02% |
+1,007,729
| New | +$5.81M |
2026 Q1
0 quarters
|
|
6
Tenaya Therapeutics
TNYA
$125M
| $2.97M | 3.58% |
4,286,933
-1,127,168
| -21% | -$832K |
2025 Q4
1 quarter
|
|
|
7
Big Sky Industrial
BSIN
$77.7M
| $1.7M | 2.04% |
+1,917,844
| New | +$1.98M |
2026 Q1
0 quarters
|
|
|
8
SCYNEXIS
SCYX
$40.6M
| $1.69M | 2.04% |
+230,978
| New | +$1.43M |
2026 Q1
0 quarters
|
|
|
9
Cyngn
CYN
$7.8M
| $1.59M | 1.92% |
+957,784
| New | +$1.86M |
2026 Q1
0 quarters
|
|
10
Jaguar Uranium Corp
JAGU
$22.8M
| $1.34M | 1.61% |
+487,500
| New | +$1.14M |
2026 Q1
0 quarters
|
|
|
11
Satellos Bioscience
MSLE
$158M
| $1.3M | 1.56% |
+230,100
| New | +$2.26M |
2026 Q1
0 quarters
|
|
|
12
Critical Metals Corp
CRML
$981M
| $1.05M | 1.26% |
132,039
-359,421
| -73% | -$4.14M |
2025 Q4
1 quarter
|
|
13
Ur-Energy
URG
$386M
| $924K | 1.11% |
+620,136
| New | +$1.01M |
2026 Q1
0 quarters
|
|
14
ProMIS Neurosciences
PMN
$86M
| $766K | 0.92% |
+60,353
| New | +$900K |
2026 Q1
0 quarters
|
|
15
Super League Enterprise
SLE
$9.77M
| $492K | 0.59% |
132,917
+28,751
| +28% | +$152K |
2025 Q4
1 quarter
|
|
16
Talphera
TLPH
$56.1M
| $441K | 0.53% |
590,481
-743,016
| -56% | -$672K |
2025 Q4
1 quarter
|
|
17
Benitec Biopharma
BNTC
$317M
| $324K | 0.39% |
30,440
-25,000
| -45% | -$289K |
2022 Q3
14 quarters
|
|
18
BriaCell Therapeutics Warrant
BCTXL
$3.04M
| $309K | 0.37% |
+300,000
| New | +$318K |
2026 Q1
0 quarters
|
|
19
Abits Group
ABTS
$3.83M
| $266K | 0.32% |
+172,761
| New | +$615K |
2026 Q1
0 quarters
|
|
20
ParaZero Technologies
PRZO
$17.7M
| $218K | 0.26% |
+282,199
| New | +$325K |
2026 Q1
0 quarters
|
|
21
Nasus Pharma
NSRX
$38.5M
| $102K | 0.12% |
+45,803
| New | +$236K |
2026 Q1
0 quarters
|
|
|
22
BriaCell Therapeutics Corp Warrant
BCTXZ
$554K
| $93.3K | 0.11% |
666,600
| – | – |
2025 Q4
1 quarter
|
|
23
DELISTED
Nutriband Inc Warrant
NTRBW
| $45K | 0.05% |
40,218
| – | – |
2021 Q4
17 quarters
|
|
24
Maris-Tech Ltd Warrants
MTEKW
| $44.9K | 0.05% |
297,600
| – | – |
2022 Q1
16 quarters
|
|
25
Renatus Tactical Acquisition Corp I Warrant
RTACW
$5.82M
| $23K | 0.03% |
50,000
| – | – |
2025 Q4
1 quarter
|
|
Similar funds
BCM
TI
LCM
AA
RCSA
YAG
CL
TWM
Empery Asset Management's Q1 2026 Portfolio in Review
As of Q1 2026, Empery Asset Management held 43 positions worth $83M, down 27% from $113M the previous quarter. Its ten largest holdings account for 92% of the portfolio.
Empery Asset Management withdrew a net $31M in Q1 2026, closing 11 positions and reducing 7 holdings. Its most notable exit was Immuneering, an estimated $17.6M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 67% of assets, up from 65% a quarter earlier, followed by Consumer Discretionary and Energy.
Against the trend, Empery Asset Management opened a new position in Venu Holding Corp worth $3.34M.
- Empery Asset Management's largest Q1 2026 buy was Venu Holding Corp: 1,007,729 shares worth $3.34M.
- Empery Asset Management added most to Super League Enterprise in Q1 2026, an estimated $152K increase.
- Empery Asset Management's biggest Q1 2026 reduction was Imperial Petroleum, cutting an estimated $9.21M.
- Empery Asset Management fully exited Immuneering in Q1 2026, selling an estimated $17.6M.
- Empery Asset Management's ten largest holdings make up 92% of its $83M portfolio in Q1 2026.
- Empery Asset Management opened 12 new positions and closed 11 in Q1 2026.
- Empery Asset Management's portfolio value fell 27% quarter-over-quarter to $83M.
Based on Empery Asset Management's 13F filing for Q1 2026, filed 8 May 2026.